Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues
Cancers · 26.11.2023 · 15 (23) · 5593
DOI: 10.3390/cancers15235593 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 26.11.2023. Verfasst von Giuseppe Marrone und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical and Surgical Sciences Department, Policlinico Universitario A. Gemelli-IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a growing indication for liver transplantation (LT). Careful candidate selection is a prerequisite to keep post-LT recurrence rates within acceptable percentages. In the pre-LT period, various types of locoregional treatments and/or systemic therapies can be used for bridging or downstaging purposes. In this context, one of the factors limiting the possibility of treatment is the degree of functional liver impairment. In the LT subject, no widely accepted indications are available to guide treatment of disease recurrence and heterogeneity exists between transplant centers. Improved liver function post LT makes multiple therapeutic strategies theoretically feasible, but patient management is complicated by the need to adjust immunosuppressive therapy and to assess potential toxicities and drug–drug interactions. Finally, there is controversy and uncertainty about the use of recently introduced immunotherapeutic drugs, mainly due to the risk of organ rejection. In this paper, we will review the most recent available literature on the management of post-transplant HCC recurrence, discussing evidence and controversies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical and Surgical Sciences Department, Policlinico Universitario A. Gemelli-IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
ORCID-Profile: Marco Biolato, Antonio Liguori, Giuseppe Bianco, Luca Miele
Zitieren
APA
Marrone, G., Leone, M. S., Biolato, M., Liguori, A., Bianco, G., Spoletini, G., Gasbarrini, A., Miele, L., & Pompili, M. (2023). Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues. Cancers, 15(23), 5593. https://doi.org/10.3390/cancers15235593
Vancouver
Marrone G, Leone MS, Biolato M, Liguori A, Bianco G, Spoletini G, et al. Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues. Cancers. 2023;15(23):5593. doi:10.3390/cancers15235593
BibTeX
@article{Marrone2023,
author = {Marrone, Giuseppe and Leone, Maria Sandrina and Biolato, Marco and Liguori, Antonio and Bianco, Giuseppe and Spoletini, Gabriele and Gasbarrini, Antonio and Miele, Luca and Pompili, Maurizio},
title = {Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues},
journal = {Cancers},
year = {2023},
volume = {15},
number = {23},
pages = {5593},
doi = {10.3390/cancers15235593}
}
EUVIMED